EUVIMEDEUVIMED entdecken
Open Access

Mammalian Target of Rapamycin Complex 1 Activation in Macrophages Contributes to Persistent Lung Inflammation following Respiratory Tract Viral Infection

Brydie R Huckestein, Kelly Zeng, Rosemary Westcott, Jonathan K Alder, Danielle Antos, Jay K Kolls, John F Alcorn

The American Journal of Pathology · 2024-03 · 194 (3) · 384-401

DOI: 10.1016/j.ajpath.2023.11.017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The American Journal of Pathology, 2024-03. Verfasst von Brydie R Huckestein und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary Medicine, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Department of Immunology,…. Hauptthemen laut MEDLINE: Influenza, Human, Orthomyxoviridae Infections, Pneumonia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Institutes of Health, NHLBI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory tract virus infections cause millions of hospitalizations worldwide each year. Severe infections lead to lung damage that coincides with persistent inflammation and a lengthy repair period. Vaccination and antiviral therapy help to mitigate severe infections before or during the acute stage of disease, but there are currently limited specific treatment options available to individuals experiencing the long-term sequelae of respiratory viral infection. Herein, C57BL/6 mice were infected with influenza A/PR/8/34 as a model for severe viral lung infection and allowed to recover for 21 days. Mice were treated with rapamycin, a well-characterized mammalian target of rapamycin complex 1 (mTORC1) inhibitor, on days 12 to 20 after infection, a time period after viral clearance. Persistent inflammation following severe influenza infection in mice was primarily driven by macrophages and T cells. Uniform manifold approximation and projection analysis of flow cytometry data revealed that lung macrophages had high activation of mTORC1, an energy-sensing kinase involved in inflammatory immune cell effector functions. Rapamycin treatment reduced lung inflammation and the frequency of exudate macrophages, T cells, and B cells in the lung, while not impacting epithelial progenitor cells or adaptive immune memory. These data highlight mTORC1's role in sustaining persistent inflammation following clearance of a viral respiratory pathogen and suggest a possible intervention for post-viral chronic lung inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanOrthomyxoviridae InfectionsPneumoniaMiceAnimalsHumansMice, Inbred C57BLLungMacrophagesInflammationSirolimusMechanistic Target of Rapamycin Complex 1TOR Serine-Threonine KinasesMammals

Substanzen

SirolimusMechanistic Target of Rapamycin Complex 1TOR Serine-Threonine Kinases

Autor:innen und Institutionen

  • Division of Pulmonary Medicine, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Division of Pulmonary Medicine, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania.
  • Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Center for Translational Research in Infection and Inflammation, Tulane School of Medicine, New Orleans, Louisiana.
  • Division of Pulmonary Medicine, Department of Pediatrics, UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Department of Immunology, University of Pittsburgh, Pittsburgh, Pennsylvania. Electronic addres…

Förderung

  • NHLBI NIH HHS
  • National Institutes of Health
  • NHLBI

Zitieren

APA

Huckestein, B. R., Zeng, K., Westcott, R., Alder, J. K., Antos, D., Kolls, J. K., & Alcorn, J. F. (2024). Mammalian Target of Rapamycin Complex 1 Activation in Macrophages Contributes to Persistent Lung Inflammation following Respiratory Tract Viral Infection. The American Journal of Pathology, 194(3), 384-401. https://doi.org/10.1016/j.ajpath.2023.11.017

Vancouver

Huckestein BR, Zeng K, Westcott R, Alder JK, Antos D, Kolls JK, et al. Mammalian Target of Rapamycin Complex 1 Activation in Macrophages Contributes to Persistent Lung Inflammation following Respiratory Tract Viral Infection. The American Journal of Pathology. 2024;194(3):384-401. doi:10.1016/j.ajpath.2023.11.017

BibTeX
@article{Huckestein2024,
  author = {Huckestein, Brydie R and Zeng, Kelly and Westcott, Rosemary and Alder, Jonathan K and Antos, Danielle and Kolls, Jay K and Alcorn, John F},
  title = {Mammalian Target of Rapamycin Complex 1 Activation in Macrophages Contributes to Persistent Lung Inflammation following Respiratory Tract Viral Infection},
  journal = {The American Journal of Pathology},
  year = {2024},
  volume = {194},
  number = {3},
  pages = {384--401},
  doi = {10.1016/j.ajpath.2023.11.017}
}
Kostenlos starten →